Endologix Inc. to Participate at Two Upcoming Investor Conferences in September  
9/6/2013 9:46:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences in September. The first conference is the 2013 Stifel Healthcare Conference in Boston.

Help employers find you! Check out all the jobs and post your resume.